Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin

AIMS: To compare the safety and efficacy of TACE using raltitrexed, oxaliplatin and epirubicin with 5-fluorouracil, oxaliplatin and epirubicin for patients with unresectable hepatocelluar carcinoma. RESULTS: Median overall survival (OS) was 7.4 months in the raltitrexed group [95% confidence interva...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Wei, Fan, Wenzhe, Zhang, Qun, Wen, Jia, Huang, Yonghui, Yang, Jianyong, Li, Jiaping, Wang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668029/
https://www.ncbi.nlm.nih.gov/pubmed/29108296
http://dx.doi.org/10.18632/oncotarget.16298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668029/
https://www.ncbi.nlm.nih.gov/pubmed/29108296
http://dx.doi.org/10.18632/oncotarget.16298

Ejemplares similares